ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Lilly, Nektar to co-develop new immunotherapy – PharmaTimes

Continue reading

2017-07-25 Michael Zand NEWS

Breakthrough in Advanced Kidney Disease by Stem Cell Genetic Med – Markets Insider

Markets InsiderBreakthrough in Advanced Kidney Disease by Stem Cell Genetic MedMarkets InsiderNevertheless, he felt the need to search the internet for other possible solutions. It was Stem Cell Genetic Med that caught his interest. After careful detai… Continue reading

2017-07-25 Michael Zand NEWS

Health Shorts: Stem cell ‘cures,’ Sugar spike, Longevity – Sarasota Herald-Tribune


PharmaTimes

Lilly, Nektar to co-develop new immunotherapy
PharmaTimes
Eli Lilly and Nektar Therapeutics have signed a pact to co-develop the latter’s experimental immunotherapy NKTR-358 for a range of autoimmune and other chronic inflammatory conditions under a deal valued at $400 million. NKTR-358 is a potential …
Nektar Therapeutics – NKTR – Stock Price Today – ZacksZacks Investment Research

all 47 news articles »

Continue reading

2017-07-25 Michael Zand NEWS

BRIEF-Cellectis is granted patent for CRISPR use in T-cells – Reuters

BRIEF-Cellectis is granted patent for CRISPR use in T-cellsReutersANNOUNCED ON MONDAY ABOUT THE GRANT BY THE EUROPEAN PATENT OFFICE OF PATENT NO. EP3004337 FOR THE INVENTION OF USING RNA-GUIDED ENDONUCLEASES, SUCH AS CAS9 OR CPF1 FOR THE GENETIC … Continue reading

2017-07-25 Michael Zand NEWS

Rosy future predicted for global synthetic biology industry – WhaTech

WhaTechRosy future predicted for global synthetic biology industryWhaTechThe top-down approach has been used to calculate the global synthetic biology market size by segment, and application. The market numbers for countries are obtained through top-do… Continue reading

2017-07-25 Michael Zand NEWS

Cellectis wins European patent for CRISPR use in T-cells – News-Medical.net

Health Shorts: Stem cell ‘cures,’ Sugar spike, Longevity
Sarasota Herald-Tribune
Stem cell clinics offering unapproved treatments for ailments from hip pains to erectile dysfunction increasingly use a federal clinical-trials database as a marketing tool — a strategy that confuses patients and exposes them to “unjustifiable” safety …

and more »

Continue reading

2017-07-25 Michael Zand NEWS

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina – Science Daily

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retinaScience DailyCRISPR-Cas9 is a powerful new technology that can target and edit certain aspects of the genome, or the complete set of genetic material of an organism. In the Nature Commu… Continue reading

2017-07-25 Michael Zand NEWS

Merck immunotherapy fails to improve survival in head and neck cancer – Reuters

Merck immunotherapy fails to improve survival in head and neck cancerReuters(Reuters) – Merck & Co said on Monday that its Keytruda immunotherapy failed to extend survival in previously treated patients with advanced head and neck cancer more than … Continue reading

2017-07-24 Michael Zand NEWS
  • 1
  • …
  • 1,453
  • 1,454
  • 1,455
  • 1,456
  • 1,457
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Cellectis wins European patent for CRISPR use in T-cells
News-Medical.net
“We have been the first to explore the potential of CRISPR in its early days in various applications, including therapeutics and food, and these early findings ultimately led to the grant of this new patent. While Cellectis has selected TALEN® as the …

and more »